发明名称 |
Intranasal oxytocin treatment to improve schizophrenia |
摘要 |
The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analog thereof having a beneficial effect. |
申请公布号 |
US9585935(B2) |
申请公布日期 |
2017.03.07 |
申请号 |
US201113812850 |
申请日期 |
2011.07.30 |
申请人 |
The Regents of the University of California |
发明人 |
Feifel David |
分类号 |
A61K38/11;A61K9/00 |
主分类号 |
A61K38/11 |
代理机构 |
Gavrilovich, Dodd & Lindsey LLP |
代理人 |
Baker, Jr. Joseph R.;Gavrilovich, Dodd & Lindsey LLP |
主权项 |
1. A method of treating schizophrenia comprising chronically intranasally administering to a patient in need thereof an oxytocin peptide at a dose of about 40-100 IU per day. |
地址 |
Oakland CA US |